Biocon Biologics Gets USFDA Approval for Biosimilar Ophthalmology Drug
May 21, 2024 11:06
Biocon Biologics has received USFDA approval for Yesafili, a biosimilar to Eylea (aflibercept), for treating various ophthalmology conditions like age-related macular degeneration.
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
